日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias

一项针对复发或难治性急性白血病成人患者的1期剂量递增试验,研究了氯法拉滨序贯递增剂量分次环磷酰胺的疗效。

Zeidan, Amer M; Ricklis, Rebecca M; Carraway, Hetty E; Yun, Hyun D; Greer, Jacqueline M; Smith, B Douglas; Levis, Mark J; McDevitt, Michael A; Pratz, Keith W; Showel, Margaret M; Gladstone, Douglas E; Gore, Steven D; Karp, Judith E

A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia

一项针对复发或难治性急性白血病患者的抗癌喹诺酮衍生物vosaroxin的Ib期研究

Lancet, J E; Ravandi, F; Ricklis, R M; Cripe, L D; Kantarjian, H M; Giles, F J; List, A F; Chen, T; Allen, R S; Fox, J A; Michelson, G C; Karp, J E